Houston, The Eagle Has Landed: Revolutionary Brain Surgery Technology Comes To Texas
Houston Methodist Hospital is the first hospital in Texas to acquire Synaptive Medical's new innovative operative solution for imaging, planning and surgical navigation for brain surgery
HOUSTON, April 19, 2016 /PRNewswire-USNewswire/ -- Houston Methodist Hospital, a recognized leader in advancing neuroscience research and advanced surgical techniques to achieve better outcomes, is pleased to announce they are the first hospital in Texas to acquire Synaptive Medical's BrightMatter Surgical Solutions. This technology is defining a new era of neurosurgical intervention and supporting physicians to achieve the possible for patients who are in need of a complex neurosurgical procedure.
"With better visualization for the surgeons, this new technology will help treat and remove tumors deep inside the brain," said Gavin Britz, M.D., chairman of neurosurgery at Houston Methodist Neurological Institute. "This technology uses patient-specific imaging which allows surgeons to plan the safest and fastest surgical route." Dr. Gavin W. Britz leads an acclaimed team of neurosurgeons and affiliated professionals and is recognized as one of the nation's foremost cerebrovascular, skull base and brain tumor surgeons.
BrightMatter™ Surgical Solutions from Synaptive Medical integrates pre-operative imaging, surgical planning, operative navigation and guidance, and a robotic visualization system. This new technology will offer unprecedented visualization of a patient's brain. Physicians are not able to see this type of information with the naked eye, and until recently, were only able to assume the location of certain tracts in a small area of the brain. The BrightMatter technology is the first of its kind that enables a surgeon to visualize the entire brain's fiber tracts and plan the best and safest route, which sometimes is not the shortest.
With a hands free robotic visualization system that stays focused on the surgical field, surgeons are able to see extraordinary details of the patients' anatomy and remain focused on the procedure. BrightMatter's technology is able to track exactly where their tools are in the patient and visualizes the patients' unique fiber tracts and planned trajectory in real time. Through automated surgical assistance, BrightMatter Surgical Solutions provides surgeons with information when they need it most while reducing the physical strain physicians can endure during complex procedures, allowing them to focus on delivering the highest quality of care.
"We are excited to partner with Houston Methodist Hospital, Dr. Britz, and his team to provide the latest in advanced technology solutions for neurosurgical planning and surgery. In the city that inspired the many to believe in the possibility of the original 'moonshot,' we are hopeful that a prominent team such as Dr. Britz's can use this technology to make a difference in the mission to beat cancer. We look forward to working together to care for patients and define a new era of neurosurgery," said Cameron Piron, CEO of Synaptive Medical.
Houston Methodist has a long history of leading the way on innovative technology, and now, using this system, surgeons are able to plan and execute their surgical intervention while acutely observing critical structures. This image informed intervention brings an unprecedented sophistication to the field of neurosurgery unlike anything seen before.
About Synaptive Medical | Synaptive Medical, a Toronto based company has a talented team of scientists and engineers specifically committed to the development of neurosurgical technologies and therapies. The result is their BrightMatter™ Neurosurgical Solutions that provide advanced tools and information to allow surgeons to focus on patient outcomes. From advanced visualization and guidance to their first hands-free surgical scope, Synaptive medical is collaborating with surgeons, hospitals and industry partners to define a new standard of care for neurosurgical intervention.
Photo - http://photos.prnewswire.com/prnh/20160419/357228
SOURCE Synaptive Medical
Share this article